Bruker to buy Carestream's preclinical imaging portfolio

Over 1400 Total Lots Up For Auction at Six Locations - MD 06/16, UT 06/18, France 06/21, PA 06/22, UT 06/24, CA 06/25


Brendon Nafziger, DOTmed News Associate Editor | September 21, 2012
Carestream Health said Friday that Bruker Corp. has agreed to buy most of its line of molecular imaging systems used in animal research. Terms of the deal, which is expected to close in several weeks, weren't disclosed.

As part of the agreement, Carestream said it would sell its preclinical in-vivo imaging equipment portfolio, such as its Xtreme and FX small animal X-ray systems and the preclinical Albira PET-SPECT-CT scanner.

Most Carestream employees working in the in-vivo imaging business would be given a chance to move over to Bruker, the Rochester, N.Y.-based company said.

Two Medical Facility Online Auctions! Call 314-429-4112

Midwest Hand Surgery Auction Closing 5/26 at 8PM. Hologic Fluoroscan Insight-FD Mini C-Arm, Nuvo Dual-Lamp Surgical Lighting System W/Control Panel, Ritter M11 Ultraclave Automatic Sterilizer & More! 2 Day Women's Treatment Center Auction Coming Soon!

Carestream said it would hold onto the rest of the molecular imaging business, such as its life science X-ray film products. The company also said it would support current customers of its Gel Logic and Image Station in-vitro imaging systems with parts and service, although new production would be discontinued.

A Carestream spokesman told DOTmed News that the digital molecular imaging segment represents only 1 percent of the company's revenue.

"This decision to sell aligns the digital in-vivo product line with a company with a primary focus on this market segment," he said by e-mail.

Bruker, which makes imaging and spectrometry equipment for the life and materials sciences industries, is based in Billerica, Mass.

You Must Be Logged In To Post A Comment